|
Nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced NSCLC: CheckMate 017/057 2-y update and exploratory cytokine profile analyses. |
|
|
Honoraria - Bristol-Myers Squibb; Celgene |
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly |
Research Funding - Millennium (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck KGaA |
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck |
Other Relationship - Bristol-Myers Squibb |
|
|
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Merck; Puma Biotechnology; Xcovery |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst) |
|
|
Honoraria - Bristol-Myers Squibb; Celgene; Heat Biologics |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
No Relationships to Disclose |
|
|
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Roche |
|
|
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD; Pfizer; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb |
Consulting or Advisory Role - Bristol-Myers Squibb |
Research Funding - Bristol-Myers Squibb |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck |
|
|
Leadership - Glycotope GmbH |
|
|
|
Stock and Other Ownership Interests - Gritstone Bio |
Honoraria - Merck Sharp & Dohme |
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme; Novartis |
Research Funding - Bristol-Myers Squibb (Inst) |
|
|
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis |
|
|
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Pfizer; Roche |
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Pfizer; Roche |
|
Wilfried Ernst Erich Eberhardt |
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Hexal; Lilly; Merck; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Hexal; Lilly; Merck; Novartis; Pfizer; Roche |
Speakers' Bureau - Boehringer Ingelheim; Merck; Novartis; Pfizer; Roche |
|
|
|
Consulting or Advisory Role - Third Rock Ventures |
Research Funding - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech |
|
|
Employment - AstraZeneca; Bristol-Myers Squibb |
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb |
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
Stock and Other Ownership Interests - Foundation Medicine; Illumina |
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Novartis; Pfizer |
Speakers' Bureau - Novartis |
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BIND Biosciences (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); ImClone Systems (Inst); Immunogen (Inst); Lilly (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); Verastem (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Novartis; Pfizer |